These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1179 related articles for article (PubMed ID: 19375766)
1. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766 [TBL] [Abstract][Full Text] [Related]
3. The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm. Panarotto D; Ardilouze JL; Tessier D; Maheux P Metabolism; 2000 Aug; 49(8):1055-62. PubMed ID: 10954026 [TBL] [Abstract][Full Text] [Related]
4. Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo. Lindmark S; Burén J; Eriksson JW Clin Endocrinol (Oxf); 2006 Sep; 65(3):301-9. PubMed ID: 16918948 [TBL] [Abstract][Full Text] [Related]
5. Fasting hyperinsulinemia associates with increased sub-clinical inflammation in first-degree relatives normal glucose tolerant women independently of the metabolic syndrome. Setola E; Monti LD; Lucotti P; Galluccio E; Oldani M; Bosi E; Piatti P Diabetes Metab Res Rev; 2009 Oct; 25(7):639-46. PubMed ID: 19685554 [TBL] [Abstract][Full Text] [Related]
6. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Nyström T; Nygren A; Sjöholm A Clin Sci (Lond); 2006 Jun; 110(6):673-81. PubMed ID: 16466346 [TBL] [Abstract][Full Text] [Related]
7. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171 [TBL] [Abstract][Full Text] [Related]
8. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923 [TBL] [Abstract][Full Text] [Related]
9. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance. Straczkowski M; Kowalska I; Nikolajuk A; Otziomek E; Adamska A; Karolczuk-Zarachowicz M; Gorska M Int J Obes (Lond); 2007 Feb; 31(2):221-5. PubMed ID: 16770329 [TBL] [Abstract][Full Text] [Related]
10. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000 [TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines. He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865 [TBL] [Abstract][Full Text] [Related]
12. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? Burén J; Lindmark S; Renström F; Eriksson JW Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640 [TBL] [Abstract][Full Text] [Related]
13. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437 [TBL] [Abstract][Full Text] [Related]
14. Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus? Mojiminiyi OA; Al Mulla F; Abdella NA Med Princ Pract; 2009; 18(2):123-9. PubMed ID: 19204431 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757 [TBL] [Abstract][Full Text] [Related]
16. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947 [TBL] [Abstract][Full Text] [Related]
17. [Plasma levels of adiponectin and tumor necrosis factor-alpha in children with obesity]. Yan WJ; Wu J; Mo J; Huang CW; Peng LW; Xu L Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):47-50. PubMed ID: 19149923 [TBL] [Abstract][Full Text] [Related]
18. Adipokine profile and C-reactive protein in pregnancy: effects of glucose challenge response versus body mass index. Verhaeghe J; van Bree R; Lambin S; Caluwaerts S J Soc Gynecol Investig; 2005 Jul; 12(5):330-4. PubMed ID: 15979544 [TBL] [Abstract][Full Text] [Related]
19. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus. Stringer DM; Sellers EA; Burr LL; Taylor CG Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895 [TBL] [Abstract][Full Text] [Related]
20. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]